The efficacy of 5-fluorouracil in human colorectal cancer is not enhanced by thymidylate synthetase inhibition with CB3717 (N10-propargyl-5,8 dideazafolic acid).

Detalles Bibliográficos
Autores principales: Cantwell, B. M., Harris, A. L.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1988
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246772/
https://www.ncbi.nlm.nih.gov/pubmed/3166908
_version_ 1782150838671638528
author Cantwell, B. M.
Harris, A. L.
author_facet Cantwell, B. M.
Harris, A. L.
author_sort Cantwell, B. M.
collection PubMed
description
format Text
id pubmed-2246772
institution National Center for Biotechnology Information
language English
publishDate 1988
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-22467722009-09-10 The efficacy of 5-fluorouracil in human colorectal cancer is not enhanced by thymidylate synthetase inhibition with CB3717 (N10-propargyl-5,8 dideazafolic acid). Cantwell, B. M. Harris, A. L. Br J Cancer Research Article Nature Publishing Group 1988-08 /pmc/articles/PMC2246772/ /pubmed/3166908 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Cantwell, B. M.
Harris, A. L.
The efficacy of 5-fluorouracil in human colorectal cancer is not enhanced by thymidylate synthetase inhibition with CB3717 (N10-propargyl-5,8 dideazafolic acid).
title The efficacy of 5-fluorouracil in human colorectal cancer is not enhanced by thymidylate synthetase inhibition with CB3717 (N10-propargyl-5,8 dideazafolic acid).
title_full The efficacy of 5-fluorouracil in human colorectal cancer is not enhanced by thymidylate synthetase inhibition with CB3717 (N10-propargyl-5,8 dideazafolic acid).
title_fullStr The efficacy of 5-fluorouracil in human colorectal cancer is not enhanced by thymidylate synthetase inhibition with CB3717 (N10-propargyl-5,8 dideazafolic acid).
title_full_unstemmed The efficacy of 5-fluorouracil in human colorectal cancer is not enhanced by thymidylate synthetase inhibition with CB3717 (N10-propargyl-5,8 dideazafolic acid).
title_short The efficacy of 5-fluorouracil in human colorectal cancer is not enhanced by thymidylate synthetase inhibition with CB3717 (N10-propargyl-5,8 dideazafolic acid).
title_sort efficacy of 5-fluorouracil in human colorectal cancer is not enhanced by thymidylate synthetase inhibition with cb3717 (n10-propargyl-5,8 dideazafolic acid).
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246772/
https://www.ncbi.nlm.nih.gov/pubmed/3166908
work_keys_str_mv AT cantwellbm theefficacyof5fluorouracilinhumancolorectalcancerisnotenhancedbythymidylatesynthetaseinhibitionwithcb3717n10propargyl58dideazafolicacid
AT harrisal theefficacyof5fluorouracilinhumancolorectalcancerisnotenhancedbythymidylatesynthetaseinhibitionwithcb3717n10propargyl58dideazafolicacid
AT cantwellbm efficacyof5fluorouracilinhumancolorectalcancerisnotenhancedbythymidylatesynthetaseinhibitionwithcb3717n10propargyl58dideazafolicacid
AT harrisal efficacyof5fluorouracilinhumancolorectalcancerisnotenhancedbythymidylatesynthetaseinhibitionwithcb3717n10propargyl58dideazafolicacid

Ejemplares similares